What is the appropriate dosing regimen of Augmentin (amoxicillin/clavulanic acid) 250 mg/5 mg for a 22‑kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for a 22kg Child

For a 22kg child, the appropriate dose of Augmentin depends on the indication and severity of infection, but typically ranges from 990mg to 1980mg of amoxicillin component per day, divided into 2-3 doses.

Standard Dosing Regimens

For Mild-to-Moderate Infections

  • Standard dose: 45 mg/kg/day of amoxicillin component divided into 2 doses (BID)
    • For 22kg child: 495mg BID (approximately 10mL of 250mg/5mL suspension twice daily)
    • Alternative: 45 mg/kg/day divided into 3 doses (TID) = 330mg TID (approximately 6.5mL three times daily)

For Severe Infections or Resistant Pathogens

  • High dose: 90 mg/kg/day divided into 2 doses (BID)
    • For 22kg child: 990mg BID (approximately 20mL of 250mg/5mL suspension twice daily)
    • This is particularly important for:
      • Recent antibiotic use within 30 days 1
      • Daycare attendance 1, 2
      • Age <2 years (though this child is likely older given weight)
      • Areas with high penicillin-resistant S. pneumoniae (>10%) 2
      • Treatment failure on standard-dose amoxicillin 1

Clinical Decision Algorithm

Choose HIGH-DOSE (90 mg/kg/day) if ANY of the following:

  • Child attends daycare
  • Received antibiotics in past 30 days
  • Concurrent conjunctivitis
  • Moderate-to-severe illness presentation
  • Failed previous amoxicillin therapy
  • Known local resistance patterns show >10% penicillin-nonsusceptible S. pneumoniae

Choose STANDARD-DOSE (45 mg/kg/day) if:

  • Mild infection
  • No recent antibiotic exposure
  • No daycare attendance
  • Age ≥2 years
  • Low local resistance rates

Formulation Considerations

The "250/5" designation typically refers to 250mg amoxicillin per 5mL suspension. However, critical caveats exist:

  • Standard Augmentin formulations contain varying ratios of clavulanate:

    • 250mg/5mL suspension contains 62.5mg clavulanate per 5mL (4:1 ratio)
    • Different formulations have different clavulanate content 3
  • Augmentin ES-600 (if available) provides 600mg amoxicillin/42.9mg clavulanate per 5mL and is specifically designed for high-dose therapy 3

    • For 22kg child: 7.5mL BID of ES-600 formulation
    • This formulation is NOT interchangeable with standard suspensions 3

Duration of Therapy

  • Acute otitis media: 10 days 1, 3
  • Acute bacterial sinusitis: 10-14 days 2
  • Community-acquired pneumonia: 7-10 days (may extend to 14 days based on clinical response) 4, 5

Administration Guidance

  • Give at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 3
  • Shake suspension well before each dose 3
  • Refrigerate reconstituted suspension; stable for 10 days 3

Common Pitfalls to Avoid

  1. Don't underdose resistant infections: Using standard-dose amoxicillin-clavulanate when high-dose is indicated leads to treatment failure, particularly with penicillin-resistant S. pneumoniae (MIC ≥2 mcg/mL) 1, 3

  2. Don't confuse formulations: ES-600 and standard suspensions have different clavulanate concentrations and are NOT interchangeable 3

  3. Don't ignore BID vs TID dosing: BID dosing (with appropriate total daily dose) reduces diarrhea incidence from 26.7% to 9.6% compared to TID dosing 6

  4. Don't use when amoxicillin alone suffices: For uncomplicated infections without β-lactamase-producing organisms, amoxicillin alone is preferred to reduce side effects and resistance pressure 7

Evidence Quality Note

The dosing recommendations are based on FDA-approved labeling 3 and high-quality pediatric infectious disease guidelines from IDSA/PIDS (2011) 4, 8 and AAP (2013) 1, 2. The high-dose regimen (90 mg/kg/day) demonstrated 98.4% bacteriologic eradication of S. pneumoniae and 89.1% clinical cure rates in rigorous clinical trials 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.